Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02860676
Title Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Diego
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.